Trial Profile
Clinical Trials Insight: 700014472
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 23 Aug 2006
Price :
$35
*
At a glance
- Drugs Vapendavir (Primary)
- Indications Rhinovirus infections
- Focus Adverse reactions
- Sponsors Biota Holdings
- 23 Aug 2006 New trial record.